[{"address1": "2656 State Street", "city": "Carlsbad", "state": "CA", "zip": "92008", "country": "United States", "phone": "619 728 4760", "website": "https://tyra.bio", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SN\u00c5P, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions. Its lead product candidate is TYRA-300, which is in Phase 1/2 clinical trials for the treatment of patients with metastatic urothelial carcinoma and other solid tumors. The company is also developing TYRA-300 for skeletal conditions, including achondroplasia, hypochondroplasia, thanatophoric dysplasia, and other FGFR3-driven genetic syndromes; TYRA-200, a candidate in Phase 1 clinical trial for bile duct and solid tumors; and TYRA-430 for the treatment of hepatocellular carcinoma. The company was incorporated in 2018 and is headquartered in Carlsbad, California.", "fullTimeEmployees": 49, "companyOfficers": [{"maxAge": 1, "name": "Dr. Todd  Harris Ph.D.", "age": 45, "title": "Co-Founder, President, CEO, Secretary, Treasurer & Director", "yearBorn": 1979, "fiscalYear": 2023, "totalPay": 1065650, "exercisedValue": 0, "unexercisedValue": 4803451}, {"maxAge": 1, "name": "Mr. Daniel  Bensen", "age": 48, "title": "Co-Founder & COO", "yearBorn": 1976, "fiscalYear": 2023, "totalPay": 630800, "exercisedValue": 0, "unexercisedValue": 2216617}, {"maxAge": 1, "name": "Dr. Robert L. Hudkins Ph.D.", "age": 68, "title": "Chief Technology Officer", "yearBorn": 1956, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ronald V. Swanson Ph.D.", "age": 60, "title": "Chief Scientific Officer", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 536188, "exercisedValue": 0, "unexercisedValue": 298928}, {"maxAge": 1, "name": "Mr. Ali D. Fawaz J.D.", "title": "General Counsel", "fiscalYear": 2023, "totalPay": 629230, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sarah  Honig", "title": "Vice President of Corporate Development & Strategy", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Liz  Pagano", "title": "Senior Vice President of Human Resources", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Piyush R. Patel Ph.D.", "age": 58, "title": "Chief Development Officer", "yearBorn": 1966, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Douglas  Warner M.D.", "age": 52, "title": "Chief Medical Officer", "yearBorn": 1972, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Erik  Goluboff", "title": "Senior Vice President of Clinical Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 6, "compensationRisk": 8, "shareHolderRightsRisk": 9, "overallRisk": 7, "governanceEpochDate": 1740787200, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 10.74, "open": 10.54, "dayLow": 10.455, "dayHigh": 11.82, "regularMarketPreviousClose": 10.74, "regularMarketOpen": 10.54, "regularMarketDayLow": 10.455, "regularMarketDayHigh": 11.82, "payoutRatio": 0.0, "beta": 1.09, "forwardPE": -5.6930695, "volume": 1105122, "regularMarketVolume": 1105122, "averageVolume": 281048, "averageVolume10days": 465220, "averageDailyVolume10Day": 465220, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 581934528, "fiftyTwoWeekLow": 9.93, "fiftyTwoWeekHigh": 29.6, "fiftyDayAverage": 13.5194, "twoHundredDayAverage": 17.86445, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 254213984, "profitMargins": 0.0, "floatShares": 20696147, "sharesOutstanding": 50603000, "sharesShort": 4076761, "sharesShortPriorMonth": 2819264, "sharesShortPreviousMonthDate": 1738281600, "dateShortInterest": 1740700800, "sharesPercentSharesOut": 0.0806, "heldPercentInsiders": 0.04639, "heldPercentInstitutions": 1.0022, "shortRatio": 16.27, "shortPercentOfFloat": 0.1499, "impliedSharesOutstanding": 54568400, "bookValue": 6.852, "priceToBook": 1.678342, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -83740000, "trailingEps": -1.61, "forwardEps": -2.02, "enterpriseToEbitda": -2.553, "52WeekChange": -0.2914356, "SandP52WeekChange": 0.09506309, "quoteType": "EQUITY", "currentPrice": 11.5, "targetHighPrice": 33.0, "targetLowPrice": 28.0, "targetMeanPrice": 30.16667, "targetMedianPrice": 30.0, "recommendationMean": 1.14286, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 360129984, "totalCashPerShare": 6.811, "ebitda": -99594000, "totalDebt": 6318000, "quickRatio": 29.26, "currentRatio": 29.549, "debtToEquity": 1.744, "returnOnAssets": -0.20209, "returnOnEquity": -0.28656, "freeCashflow": -37571876, "operatingCashflow": -63716000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "TYRA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 7.076352, "regularMarketPrice": 11.5, "corporateActions": [], "postMarketTime": 1741983811, "regularMarketTime": 1741982400, "exchange": "NMS", "messageBoardId": "finmb_650787124", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "shortName": "Tyra Biosciences, Inc.", "longName": "Tyra Biosciences, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1631712600000, "epsTrailingTwelveMonths": -1.61, "epsForward": -2.02, "epsCurrentYear": -1.5018, "priceEpsCurrentYear": -7.657478, "fiftyDayAverageChange": -2.0193996, "fiftyDayAverageChangePercent": -0.1493705, "twoHundredDayAverageChange": -6.3644505, "twoHundredDayAverageChangePercent": -0.35626343, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-09-15", "averageAnalystRating": "1.1 - Strong Buy", "cryptoTradeable": false, "postMarketChangePercent": 0.0, "postMarketPrice": 11.5, "postMarketChange": 0.0, "regularMarketChange": 0.7600002, "regularMarketDayRange": "10.455 - 11.82", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 281048, "fiftyTwoWeekLowChange": 1.5699997, "fiftyTwoWeekLowChangePercent": 0.15810671, "fiftyTwoWeekRange": "9.93 - 29.6", "fiftyTwoWeekHighChange": -18.1, "fiftyTwoWeekHighChangePercent": -0.6114865, "fiftyTwoWeekChangePercent": -29.14356, "earningsTimestampStart": 1742241600, "earningsTimestampEnd": 1742587200, "isEarningsDateEstimate": true, "trailingPegRatio": null, "__fetch_time": "2025-03-15"}]